Replies to post #2790 on Manhattan Scientifics Inc (MHTX)

[ssc]

The company has to prove that the Flynn technology works. They have been issuing p/r's for almost 4 years saying things like:

Manhattan Scientifics’ Technology Able To Detect Breast Cancer Three Years Earlier Than Mammogram

New Technology 100% Radiation Free

April 21, 2010

And yet they have not even been able to land a contract with animal testing companies. This was supposed to happen years ago since FDA approval is not required for use with animals. Obviously those p/r's were incorrect and/or very misleading. 4 years later it seems they might finally have an actual machine, but the market gives very little value to it. Lack of credibility, lack of progress, lack of transparency, but no shortage of free shares to dole out to executives and directors.

What's happening with MDA?
What happened to Steve Miller?
What are details of the 14,000,000 shares and 14,000,000 warrants; are they being dumped on the market; what is exercise price of warrants?
Why no additional metals contracts even though mentioned as a goal for years?
Why no animal testing contracts?

Based on performance over the last 4 years, executives and directors should be sitting in the penalty box, not being rewarded as if they just scored a hat trick.